This topic contains a solution. Click here to go to the answer

Author Question: A patient has been treated for severe contact dermatitis on both arms with clobetasol propionate ... (Read 63 times)

joblessjake

  • Hero Member
  • *****
  • Posts: 555
A patient has been treated for severe contact dermatitis on both arms with clobetasol propionate cream. At a follow-up visit, the primary care NP notes that the condition has cleared. The NP should:
 
  a. prescribe triamcinolone cream for 2 weeks.
  b. recommend continuing treatment for 2 more weeks.
  c. discontinue the clobetasol and schedule a follow-up visit in 2 weeks.
  d. discontinue the clobetasol and recommend prn use for occasional flare-ups.

Question 2

A patient who is taking an ACE inhibitor sees the primary care NP for a follow-up visit. The patient reports having a persistent cough. The NP should:
 
  a. consider changing the medication to an ARB.
  b. order a bronchodilator to counter the bronchospasm caused by this drug.
  c. ask whether the patient has had any associated facial swelling with this cough.
  d. reassure the patient that tolerance to this adverse effect will develop over time.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

joshraies

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

A
Treatment should be discontinued when the skin condition has resolved. Tapering the corticosteroid will prevent recurrence of the skin condition. Tapering is best done by gradually reducing the potency and dosing frequency at 2-week intervals. This patient was on a very high potency steroid, so changing to a medium frequency with follow-up in 2 weeks is an appropriate action. Discontinuing the steroid abruptly can lead to recurrence.

Answer to Question 2

A
A persistent cough may occur with ACE inhibitors and may warrant discontinuation of the drug. An ARB would be the next drug of choice because it does not have this side effect. The cough is not related to bronchospasm. Angioedema is not related to ACE inhibitorinduced cough. Patients do not develop tolerance to this side effect.





 

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

For a complete list of videos, visit our video library